PsyRX CNS Bio-Tech Ltd (TLV:PSRX)
Israel · Delayed Price · Currency is ILS · Price in ILA 87.00
0.00 (0.00%)
At close: Jul 15, 2026
PsyRX CNS Bio-Tech Market Cap
PsyRX CNS Bio-Tech has a market cap or net worth of 8.9 million as of July 20, 2026. Its market cap has increased by 47.93% in one year.
Market Cap
8.90M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
87.00
ChartMarket Cap Chart
Since July 25, 2021, PsyRX CNS Bio-Tech's market cap has decreased from 329.34M to 8.90M, a decrease of -97.30%. That is a compound annual growth rate of -51.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 8.90M | -9.09% |
| Dec 31, 2025 | 9.79M | 100.78% |
| Dec 31, 2024 | 4.87M | -44.97% |
| Dec 31, 2023 | 8.86M | -64.09% |
| Dec 29, 2022 | 24.66M | -59.42% |
| Dec 30, 2021 | 60.77M | -81.55% |
| Jul 25, 2021 | 329.34M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 113.34B |
| Kamada | 1.23B |
| InterCure | 155.79M |
| Rekah Pharmaceutical Industry | 124.31M |
| Seach Medical Group | 86.13M |
| Together Pharma | 39.22M |
| Nextage Therapeutics | 14.32M |
| Tikun Olam-Cannbit Pharmaceuticals | 2.75M |